CancerIQ Competitor Analysis
Progeny Genetics, Health Heritage, and CancerGene Connect have been acquired by Ambry Genetics, NantHeath, and Invitae respectively. CRA Health remains an independent, private company. Other requested details have been provided in the attached spreadsheet.
- Progeny Genetics "offers family history and genetic pedigree software with integrated risk assessment tools for clinical genetic services, clinicians and researchers." The company has an estimated revenue of $4.05 million.
- Health Heritage was an online genomic medicine decision support application that aggregates and analyzes data from medical records, genetic tests, and family history to assess disease risk. The company has been fully integrated into NantHealth after it was acquired and is no longer existing.
- CancerGene Connect is a solution developed by clinicians for clinicians to help streamline the collection, analysis, and management of patient family genetic history information. The company has an estimated revenue of $4 million.
- CRA Health provides a cancer assessment solution for the identification and assessment of patients with a high risk of cancer, especially breast cancer. The company has an estimated revenue of $7 million.
We have provided all the requested information in the attached spreadsheet. However, note that we have provided revenue and employee count estimates available as the companies were private companies that don't publish official revenue and employee count data publicly.